NDC 68462-0405-60
ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE 25 mg/1, 200 mg/1 CAPSULE
Available — 2-Day Shipping
NDC
68462-0405-60
Generic Name
ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE
Brand Name
ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE
Strength
25 mg/1, 200 mg/1
Dosage Form
CAPSULE
Route
ORAL
Package Size
—
Labeler
Glenmark Pharmaceuticals Inc., USA
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. • Aspirin and extended-release dipyridamole capsules are a combination of aspirin and dipyridamole, antiplatelet agents, indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis ( 1 )
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 68462-0405-60 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).